FasterCures Advisory Board

An image of a man named Alex Azar. He is standing in front of a bookshelf and smiling at the camera. He is middle-aged in appearance, has white skin, short brown hair, and a gray-ish brown stubbled beard. He is wearing a suit jacket over a white collared shirt with a blue and yellow striped tie, and round glasses.

Alex M. Azar II

Alex Azar has extensive health care experience in the senior-most levels of the US government and the private sector, giving him a unique perspective and background.
A headshot of an older adult man with short gray hair and white skin. He is wearing circular glasses, a gray suit, and a red tie.

John Halamka

John D. Halamka, MD, is president of the Mayo Clinic Platform, a digital initiative that transforms health care by bringing together solution developers, data partners, and health-care service providers.
An image of a bald adult man with a stubbly beard and brown skin. He is wearing round glasses and a gray sweater and smiling at the camera.

John Wigneswaran

John Wigneswaran, MD, (Wig) is Optum Rx's chief clinical officer, overseeing pharmacy benefit clinical operations for its commercial, health plan, government, and union clients, clinical product development, drug trends, and specialty medication strategy. He currently serves on the National Kidney Foundation's board of directors.
An image of an older adult man with white and slightly tan skin and short white hair. It is an image of mostly his head and he is speaking into an earpiece microphone and wearing a blue suit and tie. He is against a black background.

Gregory Simon

Gregory Simon is the president of Simonovation, LLC, an international consulting firm in science and technology policy.
person with short cropped hair in black suit and white button up shirt sitting in red chair

Christopher Austin

Christopher Austin, MD, is senior vice president of Research Technologies at GSK, where he is responsible for the identification and validation of novel genetic targets aligned with the core therapeutic areas, and molecules to modulate them.
A smiling light-skinned male-presenting person with short, gray hair wearing a suit against a light background

Jonathan Simons

Jonathan W. Simons is an American physician-scientist, medical oncologist, and leader in prostate cancer research. Simons is the Chief Science Officer and Medical Director of the Marcus Foundation.
A smiling light-skinned male-presenting person with short, brown hair wearing a suit against a white background

Richard Merkin

Richard Merkin is the CEO and founder of the Heritage Group. Under his stewardship, the Heritage Group has become the largest, physician-owned and -operated integrated delivery system in the United States with more than 50 related health-care companies.
A light-skinned male-presenting person with gray hair wearing a suit jacket against a blurred background

Shmuel Meitar

Shmuel Meitar is the founder of Time to Know, the first comprehensive digital teaching platform. He established Time to Know in 2004 as a philanthropic endeavor in Israel and expanded it into an international business.
A light-skinned male-presenting person with short, dark hair wearing a suit jacket against a blurred background

Mark McClellan

Mark McClellan is the Robert J. Margolis Professor of Business, Medicine, and Policy, and founding director of the Duke-Margolis Center for Health Policy at Duke University. McClellan is a doctor and an economist who has addressed a wide range of strategies and policy reforms to improve health care, including payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and strategies for more effective biomedical innovation.
A light-skinned female-presenting person with long, red hair wearing a suit against a blurred dark background

Michelle Longmire

Dr. Michelle Longmire is mission-driven to accelerate the development of new therapies for disease as the founder and Chief Executive Officer of Medable. A Stanford-trained physician-scientist, Dr. Longmire identified critical barriers to drug development and founded Medable to pioneer a new category of clinical trial technologies that remove traditional roadblocks to participation and radically accelerate the research process.
Subscribe to FasterCures Advisory Board